Reuters logo
BRIEF-BTG to buy targeted therapies arm of Nordion
May 23, 2013 / 6:15 AM / 5 years ago

BRIEF-BTG to buy targeted therapies arm of Nordion

LONDON, May 23 (Reuters) - BTG PLC : * Proposed acquisition of therasphere * To buy the targeted therapies division of nordion, for approximately US$200

million (£133 million) * Balance funded by part of the net proceeds of a placing of up to 32.8 million

new ordinary shares * Deal creates a leader in interventional oncology

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below